Rani Therapeutics Newsroom

H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 19 06:31 ET

Rani Therapeutics Hldgs Analyst Ratings

BenzingaNov 19 06:17 ET

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)

TipRanksNov 17 21:13 ET

Maxim Group Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 15 16:31 ET

Maxim Group Remains a Buy on Rani Therapeutics Holdings (RANI)

TipRanksNov 15 15:47 ET

Maxim Group Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsOct 22 16:32 ET

Oppenheimer Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsOct 18 08:35 ET

Analysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)

TipRanksOct 18 07:53 ET

Rani Therapeutics Hldgs Analyst Ratings

BenzingaOct 18 06:52 ET

H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 18 06:37 ET

Buy Rating Affirmed for Rani Therapeutics: Promising Developments in Oral Obesity Treatment With RaniPill

TipRanksOct 18 06:28 ET

Rani Therapeutics Hldgs Analyst Ratings

BenzingaAug 16 13:28 ET

Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)

TipRanksAug 16 06:37 ET

H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Cuts Target Price to $9

Moomoo NewsAug 16 06:36 ET

CCORF Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsAug 14 07:34 ET

Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)

TipRanksAug 14 07:24 ET

Innovative Oral Delivery Platform Drives Buy Rating for Rani Therapeutics Holdings

TipRanksAug 8 15:02 ET

Analysts Offer Insights on Healthcare Companies: Lumos Pharma (LUMO) and Rani Therapeutics Holdings (RANI)

TipRanksAug 7 09:53 ET

Rani Therapeutics Price Target Announced at $17.00/Share by Oppenheimer

Dow JonesAug 2 05:53 ET

Rani Therapeutics Hldgs Analyst Ratings

BenzingaAug 2 05:42 ET